Boehringer Ingelheim Animal Health Usa Inc. Sustainability Profile
Boehringer Ingelheim Animal Health USA Inc., a prominent subsidiary of the global pharmaceutical company Boehringer Ingelheim, is headquartered in the United States. Established in 1885, the company has evolved into a leader in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence across North America, Boehringer Ingelheim Animal Health is renowned for its comprehensive portfolio of vaccines, pharmaceuticals, and diagnostic tools that enhance animal welfare and productivity. The company’s commitment to research and development has led to significant milestones, including advancements in vaccine technology and parasiticides. Boehringer Ingelheim Animal Health is recognised for its unique approach to animal care, combining scientific expertise with a deep understanding of animal health needs. As a key player in the market, the company continues to achieve notable success, reinforcing its position as a trusted partner in animal health.
DitchCarbon Score
How does Boehringer Ingelheim Animal Health Usa Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boehringer Ingelheim Animal Health Usa Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boehringer Ingelheim Animal Health USA Inc. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of C.H. Boehringer Sohn AG & Co. KG, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Boehringer Ingelheim Animal Health USA Inc. This lack of specific initiatives suggests that the company may still be in the process of developing its climate strategy or reporting framework. Given the absence of direct emissions data and reduction initiatives, it is essential to consider the broader context of the animal health industry, which is increasingly focusing on sustainability and carbon footprint reduction. Companies in this sector are often encouraged to adopt science-based targets and align with global climate commitments to mitigate their environmental impact. In summary, while Boehringer Ingelheim Animal Health USA Inc. does not currently report specific emissions or reduction targets, its affiliation with C.H. Boehringer Sohn AG & Co. KG may provide a framework for future climate action and emissions reporting.
How Carbon Intensive is Boehringer Ingelheim Animal Health Usa Inc.'s Industry?
How Carbon Intensive is Boehringer Ingelheim Animal Health Usa Inc.'s Location?
Boehringer Ingelheim Animal Health Usa Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Boehringer Ingelheim Animal Health Usa Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
